Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Mar 04, 2024 (filed on Mar 06, 2024)Insider Name:Bourque Michael J.Ownership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:75,000Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Somer JasonOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:21,996Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Somer JasonOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-4,680Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Somer JasonOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-1,894Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Somer JasonOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-576Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Somer JasonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-4,576Price:$7.03
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Somer JasonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:7,150Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Smith Kevin Raymond MerrillOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:85,000Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Glezer StanislavOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:43,993Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Glezer StanislavOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-9,360Price:--
Filings by filing date
-
Mar 04, 2024 (filed on Mar 06, 2024)Insider Name:Bourque Michael J.Ownership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:75,000Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Somer JasonOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:21,996Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Somer JasonOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-4,680Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Somer JasonOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-1,894Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Somer JasonOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-576Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Somer JasonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-4,576Price:$7.03
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Somer JasonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:7,150Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Smith Kevin Raymond MerrillOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:85,000Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Glezer StanislavOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:43,993Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Glezer StanislavOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-9,360Price:--
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 859 WARD DRIVE GOLETA CA 93111 |
Tel: | N/A |
Website: | https://www.inogen.com |
IR: | See website |
Key People | ||
Kevin R. Smith President, Chief Executive Officer, Director | Michael J. Bourque Chief Financial Officer, Executive Vice President, Treasurer | Stanislav Glezer Executive Vice President, Chief Technology Officer |
Jason Somer Executive Vice President, General Counsel, Corporate Secretary | Gregoire Ramade Chief Commercial Officer |
Business Overview |
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device. |
Financial Overview |
For the fiscal year ended 31 December 2023, Inogen Inc revenues decreased 16% to $315.7M. Net loss increased 22% to $102.4M. Revenues reflect U.S. revenue segment decrease of 18% to $226.3M, Non-U.S. revenue segment decrease of 12% to $89.4M. Higher net loss reflects General and administ increase of 95% to $71.5M (expense), Research and Development - Balancing increase of 46% to $18.3M (expense). |
Employees: | 834 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $37.53M as of Dec 31, 2023 |
Annual revenue (TTM): | $315.66M as of Dec 31, 2023 |
EBITDA (TTM): | -$66.36M as of Dec 31, 2023 |
Net annual income (TTM): | -$102.45M as of Dec 31, 2023 |
Free cash flow (TTM): | -$30.25M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 23,546,871 as of Apr 8, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |